SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D


                    Under the Securities Exchange Act of 1934
                                (Amendment No. 3)


                               Color Imaging, Inc.
                     -------------------------------------
                                (Name of Issuer)

                            $0.01 par value per share
                      -------------------------------------
                         (Title of Class of Securities)

                                   196245 10 4
                      -------------------------------------
                                 (CUSIP Number)

                               Robert F. Dow, Esq.
                           ARNALL GOLDEN GREGORY LLP
                                 171 17th Street
                                   Suite 2100
                             Atlanta, Georgia 30363
                                  404-873-8500
                      -------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)

                                  May 18, 2004
                      -------------------------------------
             (Date of Event which Requires Filing of this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  that is the subject of this  Schedule  13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box |_|.

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the schedule,  including all exhibits.  See ss. 240.13d-7(b) for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but shall be  subject  to all other  provisions  of the Act,  (however,  see the
Notes).





CUSIP NO. 196245 10 4                                                PAGE 2 of 5



================================================================================
1    Name of Reporting Persons I.R.S. Identification Nos. of Above Persons

     Sueling Wang
================================================================================
2    Check the Appropriate Box if a Member of a Group                    (a) [X]
                                                                         (b) [_]
================================================================================
3    SEC Use Only

================================================================================
4    Source of Funds

     00
================================================================================
5    Check Box if Disclosure of Legal  Proceedings is Required Pursuant to Items
     2(d) or 2(e)                                                            [_]

================================================================================
6    Citizenship or Place of Organization

     Taiwan, R.O.C.
================================================================================
7    Sole Voting Power

     1,315,347(1)
================================================================================
8    Shared Voting Power
     
     741,204(2)
================================================================================
9    Sole Dispositive Power

     1,315,347(1)
================================================================================
10   Shared Dispositive Power

     741,204(2)
================================================================================
11   Aggregate Amount Beneficially Owned by Each Reporting Person

     2,056,551(1)(2)
================================================================================
12   Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares   [_]

================================================================================
13   Percent of Class Represented by Amount in Row (11)

     15.44 percent
================================================================================
14   Type of Reporting Person

     IN
================================================================================

(1)  Includes 350,000 shares subject to options that are currently exercisable.

(2)  Includes  141,264  shares held by the spouse of the reporting  person,  and
     600,000  shares  held  by his  children.  The  reporting  person  disclaims
     beneficial ownership of these shares.







CUSIP NO. 196245 10 4                                                PAGE 3 of 5


ITEM 1.  SECURITY AND ISSUER

     This statement relates to the common stock,  $0.01 par value, per share, of
Color Imaging,  Inc., a Delaware  corporation  ("Color Imaging").  The principal
executive office of Color Imaging is located at:

      4350 Peachtree Industrial Boulevard
      Suite 100
      Norcross, Georgia  30071

ITEM 2.  IDENTITY AND BACKGROUND

     (a)  This  Statement  on Schedule 13D is being filed by Dr.  Sueling  Wang,
          President  and  Director of the Issuer.  The  business  address of Dr.
          Sueling Wang is Color Imaging,  Inc., 4350 Peachtree Industrial Blvd.,
          Suite 100, Norcross, Georgia 30071.

     (b)  The business address of Dr. Sueling Wang is Color Imaging,  Inc., 4350
          Peachtree Industrial Blvd., Suite 100, Norcross, Georgia 30071.

     (c)  The  reporting  person is a Director of Color  Imaging,  Inc. and Vice
          Chairman of the Board.  The address of Sueling Wang is 3450  Peachtree
          Industrial Blvd, Suite 100, Norcross, GA 30071 USA

     (d)  During  the  past  five  years,  the  reporting  person  has not  been
          convicted in a criminal  proceeding  (excluding  traffic violations or
          similar misdemeanors).

     (e)  During the past five years,  the reporting person was not a party to a
          civil  proceeding  of a judicial or  administrative  body of competent
          jurisdiction  as a result of which such  person was or is subject to a
          judgment,  decree or final order  enjoining  future  violations  of or
          prohibiting  or  mandating   activity  subject  to  federal  or  state
          securities laws or finding any violation with respect to such laws.

     (f)  The reporting person above is a citizen of the United States.

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

Dr. Wang acquired  50,000 shares of common stock and warrants to purchase 50,000
shares of common stock from the Issuer in a private  transaction  on December 1,
2001 in  exchange  for  $100,000.  The  Issuer  granted to Dr.  Wang  additional
warrants to purchase  450,000  shares of common stock based on the amount of his
total  investment.  Dr. Wang exercised  these warrants on December 11, 2001. Dr.
Wang used personal funds to acquire the above securities from the Issuer. On May
18, 2004, the Issuer granted options to purchase 100,000 shares of common stock,
at $0.54 per share, to the reporting person.

ITEM 4.  PURPOSE OF TRANSACTION

See Item 3 above.  Dr. Wang  acquired  such  securities in order to increase his
equity ownership in the Issuer and for personal use.

     (a)-(j) None.

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER

     (a)  See Item 7-13 of cover page.

     (b)  Sueling  Wang has the sole  power to vote  and  dispose  of  1,315,347
          shares of common  stock of the Issuer.  Dr. Wang shares  voting  power
          with  respect to 741,204  shares of common  stock,  representing:  (a)
          141,204 shares of common stock  beneficially  held by Dr. Wang's wife,




CUSIP NO. 196245 10 4                                                PAGE 4 of 5



          Yik-Li Sih, and (b) 600,000 shares of common stock  beneficially  held
          by his three  children,  with his wife and three  children.  Dr.  Wang
          disclaims  beneficial ownership of such 156,000 shares and warrants to
          purchase 100,000 shares.

     The residential address of Yik-li Sih is 1105 Ascott Valley Drive,  Duluth,
Georgia 30096. Ms. Sih's principal occupation is real estate investor.

     During the last five years,  Ms. Sih has not been  convicted  in a criminal
proceeding (excluding traffic violations or similar  misdemeanors),  nor has Ms.
Sih been a party to a civil proceeding of a judicial or  administrative  body of
competent jurisdiction and as a result of such proceeding was or is subject to a
judgment,  decree or final order enjoining future  violations of, or prohibiting
or mandating  activities subject to, Federal or state securities laws or finding
any violation with respect to such laws. Ms. Sih is a U.S. citizen.

     The residence  address for Daniel Wang,  Michael Wang,  Elizabeth Wang, and
Justin Wang is 1105 Ascott Valley Drive,  Duluth,  Georgia  30096.  Daniel Wang,
Michael Wang and Elizabeth Wang are college students and Justin Wang is a minor.

     During the last five years, Daniel Wang, Michael Wang,  Elizabeth Wang, and
Justin Wang have not been convicted in a criminal proceeding  (excluding traffic
violations  or  similar  misdemeanors),  nor have  Daniel  Wang,  Michael  Wang,
Elizabeth Wang, and Justin Wang been a party to a civil proceeding of a judicial
or  administrative  body  of  competent  jurisdiction  and as a  result  of such
proceeding  was or is subject to a  judgment,  decree or final  order  enjoining
future violations of, or prohibiting or mandating activities subject to, Federal
or state  securities  laws or finding any  violation  with respect to such laws.
Daniel Wang, Michael Wang, Elizabeth Wang, and Justin Wang are U.S. citizens.

     (c)  See Item 3. No other  transactions  in Color Imaging  securities  have
          been effected by the reporting person within the last sixty days.

     (d)  No other  person  has the right to  receive or the power to direct the
          receipt of  dividends  from,  or the  proceeds  from the sales of, the
          securities of Color Imaging.

     (e)  Not applicable.

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER

     Not applicable.

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS

     None.







CUSIP NO. 196245 10 4                                                PAGE 5 of 5

                                    SIGNATURE

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


Dated:  January 26, 2005


                                        /s/      Sueling Wang                   
                                        ----------------------------------------
                                                 Sueling Wang